KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Operating Expenses (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Other Operating Expenses for 7 consecutive years, with $26000.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 100.8% to $26000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$156000.0 through Dec 2025, down 100.44% year-over-year, with the annual reading at -$156000.0 for FY2025, 100.44% down from the prior year.
  • Other Operating Expenses hit $26000.0 in Q4 2025 for Vir Biotechnology, up from -$11000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $90.1 million in Q1 2022 to a low of -$3.3 million in Q4 2024.
  • Historically, Other Operating Expenses has averaged $13.9 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: surged 2340.65% in 2022 and later crashed 190.91% in 2025.
  • Year by year, Other Operating Expenses stood at $56.9 million in 2021, then plummeted by 89.46% to $6.0 million in 2022, then decreased by 6.29% to $5.6 million in 2023, then tumbled by 158.02% to -$3.3 million in 2024, then surged by 100.8% to $26000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for VIR at $26000.0 in Q4 2025, -$11000.0 in Q3 2025, and -$161000.0 in Q2 2025.